Immucell Corp Stock
Your prediction
Immucell Corp Stock
The Immucell Corp price is unchanged compared to yesterday.
Pros and Cons of Immucell Corp in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | 0.000% | 3.659% | 0.000% | 0.000% | 0.000% | -26.087% | -40.351% |
| Larimar Therapeutics Inc. | -1.550% | -13.605% | -11.806% | -26.163% | -23.494% | -47.737% | -83.067% |
| aTyr Pharma Inc | -10.690% | 0.000% | 9.346% | -84.441% | -2.500% | -71.996% | -85.662% |
| Inotiv Inc. | 5.670% | -17.222% | -40.400% | -92.587% | -30.374% | -95.973% | -97.050% |
News
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company